Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biocatalysis and Biotransformation is Scopus-indexed (Q3, CiteScore 3.5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1024-2422Verify ISSN ↗1029-2446Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 181 / 325 | 44th | Q3 |
| Biochemistry | 296 / 448 | 34th | Q3 |
| Catalysis | 52 / 74 | 30th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1987–present, best quartile Q3, CiteScore 3.5.
Biocatalysis and Biotransformation is Q3 in Biotechnology (rank 181 of 325), Q3 in Biochemistry (rank 296 of 448) and Q3 in Catalysis (rank 52 of 74), by CiteScore 2025.
Biocatalysis and Biotransformation is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.5, which places it in quartile Q3 at the 44th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.291, quartile Q3, with an H-index of 56.
Biocatalysis and Biotransformation is published by Taylor and Francis Ltd. Its print ISSN is 1024-2422 and its online ISSN is 1029-2446.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biocatalysis and Biotransformation has an h-index of 58 and a 2-year mean of 1.24 citations per paper (OpenAlex). Its Scopus CiteScore is 3.5, quartile Q3. On 2-year citations it ranks #217 of 309 Scopus journals in Biotechnology.
Biocatalysis and Biotransformation published 38 papers in 2025; its busiest recent year was 2017 with 84. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from India (19.7%), Spain (18.1%) and China (7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.